Dougan Brady W, a director at Humacyte, Inc. ($HUMA), sold shares on the open market three times in the last year, totaling $3.73 million. His most recent sale occurred on August 20, 2025. These sales rank 2348th among 11,678 insiders in our database, where the average is $8.6 million across 6.37 transactions. He made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 16, 2025 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | A | Stock Options (right to buy) | 311100 | $0.00 | 311,100.0000 | 187,271,321 | 9999.99% | 0.17% |
| Aug. 20, 2025 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | S | Common Stock | 591685 | $1.58 | 1,392,091.0000 | 155,118,816 | 29.83% | 0.38% |
| Aug. 19, 2025 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | S | Common Stock | 1100000 | $1.63 | 1,983,776.0000 | 155,118,816 | 35.67% | 0.71% |
| Aug. 18, 2025 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | S | Common Stock | 549360 | $1.83 | 3,083,776.0000 | 155,118,816 | 15.12% | 0.35% |
| June 12, 2025 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | A | Stock Options (right to buy) | 0 | $0.00 | 0.0000 | 155,118,816 | 0.00% | 0.00% |
| Jan. 21, 2025 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | A | Stock Options (right to buy) | 1130311 | $0.00 | 1,130,311.0000 | 0 | 9999.99% | 0.00% |
| Dec. 19, 2024 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | A | Stock Options (right to buy) | 525 | $0.00 | 2,625.0000 | 0 | 25.00% | 0.00% |
| Nov. 19, 2024 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | P | Common Stock | 1797 | $4.44 | 3,633,136.0000 | 0 | 0.05% | 0.00% |
| Nov. 19, 2024 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | S | Common Stock | 427459 | $4.34 | 3,892,708.0000 | 0 | 9.89% | 0.00% |
| Nov. 20, 2024 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | S | Common Stock | 261369 | $4.40 | 3,631,339.0000 | 0 | 6.71% | 0.00% |
| Nov. 18, 2024 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | S | Common Stock | 811172 | $4.44 | 4,320,167.0000 | 0 | 15.81% | 0.00% |
| Sept. 10, 2024 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | S | Common Stock | 288674 | $5.23 | 5,131,339.0000 | 0 | 5.33% | 0.00% |
| Sept. 9, 2024 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | S | Common Stock | 157704 | $5.42 | 5,420,013.0000 | 0 | 2.83% | 0.00% |
| Aug. 29, 2024 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | P | Common Stock | 1222 | $6.55 | 5,577,717.0000 | 0 | 0.02% | 0.00% |
| Aug. 28, 2024 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | S | Common Stock | 277090 | $6.47 | 5,928,607.0000 | 0 | 4.47% | 0.00% |
| Aug. 29, 2024 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | S | Common Stock | 352112 | $6.35 | 5,576,495.0000 | 0 | 5.94% | 0.00% |
| Aug. 27, 2024 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | S | Common Stock | 252676 | $6.71 | 6,205,697.0000 | 0 | 3.91% | 0.00% |
| June 13, 2024 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | A | Stock Options (right to buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2024 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | S | Common Stock | 282000 | $7.09 | 6,806,521.0000 | 0 | 3.98% | 0.00% |
| June 11, 2024 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | S | Common Stock | 76630 | $7.02 | 6,729,891.0000 | 0 | 1.13% | 0.00% |
| June 12, 2024 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | S | Common Stock | 271518 | $7.30 | 6,458,373.0000 | 0 | 4.03% | 0.00% |
| June 4, 2024 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | P | Common Stock | 2362 | $6.35 | 7,088,521.0000 | 0 | 0.03% | 0.00% |
| May 31, 2024 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | S | Common Stock | 716573 | $7.78 | 7,371,438.0000 | 0 | 8.86% | 0.00% |
| May 31, 2024 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | S | Common Stock | 93213 | $8.93 | 7,278,225.0000 | 0 | 1.26% | 0.00% |
| June 3, 2024 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | S | Common Stock | 190214 | $7.42 | 7,088,011.0000 | 0 | 2.61% | 0.00% |
| June 4, 2024 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | S | Common Stock | 1852 | $7.28 | 7,086,159.0000 | 0 | 0.03% | 0.00% |
| June 3, 2024 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | P | Common Stock | 2050 | $7.37 | 8,088,011.0000 | 0 | 0.03% | 0.00% |
| Dec. 8, 2023 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | A | Stock Options (right to buy) | 803000 | $0.00 | 803,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 11, 2023 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | A | Stock Options (right to buy) | 525 | $0.00 | 2,100.0000 | 0 | 33.33% | 0.00% |
| Oct. 10, 2023 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | M | Common Stock | 114420 | $1.19 | 8,085,961.0000 | 0 | 1.44% | 0.00% |
| Oct. 10, 2023 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | M | Stock Options (right to buy) | 114420 | $0.00 | 48,176.0000 | 0 | 70.37% | 0.00% |
| Sept. 14, 2023 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | S | Common Stock | 2000000 | $2.78 | 7,971,541.0000 | 0 | 20.06% | 0.00% |
| Aug. 17, 2023 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | S | Common Stock | 570174 | $3.68 | 11,200,963.0000 | 0 | 4.84% | 0.00% |
| Aug. 18, 2023 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | S | Common Stock | 626979 | $3.57 | 10,573,984.0000 | 0 | 5.60% | 0.00% |
| Aug. 21, 2023 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | S | Common Stock | 602443 | $3.39 | 9,971,541.0000 | 0 | 5.70% | 0.00% |
| June 15, 2023 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | A | Stock Options (right to buy) | 8500 | $0.00 | 8,500.0000 | 0 | 9999.99% | 0.00% |
| June 15, 2023 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | S | Common Stock | 500000 | $3.12 | 11,771,137.0000 | 0 | 4.07% | 0.00% |
| June 13, 2023 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | S | Common Stock | 4875000 | $2.60 | 12,271,137.0000 | 0 | 28.43% | 0.00% |
| May 25, 2023 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | S | Common Stock | 2625000 | $2.75 | 17,146,137.0000 | 0 | 13.28% | 0.00% |
| March 1, 2023 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | M | Common Stock | 100000 | $1.19 | 19,771,137.0000 | 0 | 0.51% | 0.00% |
| March 1, 2023 | Humacyte, Inc. | $HUMA | Dougan Brady W | Director | M | Stock Options (right to buy) | 100000 | $0.00 | 162,596.0000 | 0 | 38.08% | 0.00% |